|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Cash Flows from Operating Activities | ||||
| Net loss | ||||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Stock-based compensation expense | ||||
| Depreciation | ||||
| Depreciation and amortization | ||||
| Provision for losses on accounts receivable | ||||
| Amortization of operating right-of-use asset | ||||
| Increase (decrease) in cash resulting from changes in: | ||||
| Accounts receivable | ||||
| Inventory | ||||
| Prepaid expenses and other assets | ||||
| Accounts payable | ||||
| Accrued expenses | ||||
| Operating lease liability | ||||
| Net cash used in operating activities | ||||
| Cash Flows from Investing Activities | ||||
| Sales of short-term investments | ||||
| Purchases of short-term investments | ||||
| Purchase of assets from SiVantage, Inc. | ||||
| Purchases of property and equipment | ||||
| Net cash used in investing activities | ||||
| Cash Flows from Financing Activities | ||||
| Gross proceeds from issuance of common stock, prefunded warrants, and warrants | ||||
| Gross proceeds from exercise of warrants under inducement agreement | ||||
| Gross proceeds from issuance of common stock and warrants | ||||
| Gross proceeds from issuance of Series A convertible preferred stock | ||||
| Gross proceeds from issuance of Series B convertible preferred stock | ||||
| Proceeds from issuance of common stock, net of issuance costs | ||||
| Gross proceeds from issuance of convertible notes payable | ||||
| Gross proceeds from exercise of warrants | ||||
| Deferred offering costs | ||||
| Offering costs | ||||
| Net cash provided by financing activities | ||||
| Effect of foreign currency translation on cash flow | ||||
| Net (Decrease) Increase in Cash and Cash Equivalents | ||||
| Cash and Cash Equivalents at Beginning of Year | ||||
| Cash and Cash Equivalents at End of Year | ||||
| Cash at End of Year | ||||
| Non-cash investment and financing activities: | ||||
| Preferred stock issued upon conversion of debt and accrued interest, net of unamortized debt issuance costs | ||||
| Warrant modification costs | ||||
| Preferred stock issued upon conversion of debt and accrued interest | ||||
| Reclassification of deferred offering costs to additional paid-in capital | ||||
| Common stock issued upon conversion of Series A preferred stock | ||||
| Common stock issued for purchase of assets from SiVantage, Inc. | ||||
| Contingent consideration for purchase of assets from SiVantage, Inc. | ||||
Loading...